VJHemOnc is committed to improving our service to you

ASH 2019 | Lenalidomide maintenance in MM: data update

VJHemOnc is committed to improving our service to you

Graham Jackson

Graham Jackson, MA, MB BS, FRCP, FRCPath, MD, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK, outlines the updated data on lenalidomide maintenance therapy in multiple myeloma (MM). This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter